GB9819032D0 - Chemical compounds IV - Google Patents

Chemical compounds IV

Info

Publication number
GB9819032D0
GB9819032D0 GBGB9819032.5A GB9819032A GB9819032D0 GB 9819032 D0 GB9819032 D0 GB 9819032D0 GB 9819032 A GB9819032 A GB 9819032A GB 9819032 D0 GB9819032 D0 GB 9819032D0
Authority
GB
United Kingdom
Prior art keywords
alkyl
disorders
alkoxy
hydrogen
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9819032.5A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ligand UK Research Ltd
Original Assignee
Cerebrus Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerebrus Ltd filed Critical Cerebrus Ltd
Priority to GBGB9819032.5A priority Critical patent/GB9819032D0/en
Publication of GB9819032D0 publication Critical patent/GB9819032D0/en
Priority to DE69930397T priority patent/DE69930397T2/de
Priority to PCT/GB1999/002875 priority patent/WO2000012481A2/en
Priority to ES99943082T priority patent/ES2260931T3/es
Priority to JP2000571048A priority patent/JP2002525280A/ja
Priority to US09/763,886 priority patent/US6552062B1/en
Priority to EP99943082A priority patent/EP1129078B1/en
Priority to AU56367/99A priority patent/AU5636799A/en
Priority to CA002341612A priority patent/CA2341612A1/en
Priority to AT99943082T priority patent/ATE320419T1/de
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
GBGB9819032.5A 1998-09-01 1998-09-01 Chemical compounds IV Ceased GB9819032D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GBGB9819032.5A GB9819032D0 (en) 1998-09-01 1998-09-01 Chemical compounds IV
AT99943082T ATE320419T1 (de) 1998-09-01 1999-09-01 Indazolderivate mit 5-ht2-rezeptor-aktivität
JP2000571048A JP2002525280A (ja) 1998-09-01 1999-09-01 ５−ｈｔ２レセプター活性を有するインダゾール誘導体
PCT/GB1999/002875 WO2000012481A2 (en) 1998-09-01 1999-09-01 Indazole derivatives with 5-ht2 receptor activity________________
ES99943082T ES2260931T3 (es) 1998-09-01 1999-09-01 Derivados de indazol con actividad sobre el receptor 5-ht2.
DE69930397T DE69930397T2 (de) 1998-09-01 1999-09-01 Indazolderivate mit 5-ht2-rezeptor-aktivität
US09/763,886 US6552062B1 (en) 1998-09-01 1999-09-01 Indazole derivatives with 5-HT2 receptor activity
EP99943082A EP1129078B1 (en) 1998-09-01 1999-09-01 Indazole derivatives with 5-ht2 receptor activity
AU56367/99A AU5636799A (en) 1998-09-01 1999-09-01 Chemical compounds iv
CA002341612A CA2341612A1 (en) 1998-09-01 1999-09-01 Indazole derivatives with 5-ht2 receptor activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9819032.5A GB9819032D0 (en) 1998-09-01 1998-09-01 Chemical compounds IV

Publications (1)

Publication Number Publication Date
GB9819032D0 true GB9819032D0 (en) 1998-10-28

Family

ID=10838164

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9819032.5A Ceased GB9819032D0 (en) 1998-09-01 1998-09-01 Chemical compounds IV

Country Status (10)

Country Link
US (1) US6552062B1 (enExample)
EP (1) EP1129078B1 (enExample)
JP (1) JP2002525280A (enExample)
AT (1) ATE320419T1 (enExample)
AU (1) AU5636799A (enExample)
CA (1) CA2341612A1 (enExample)
DE (1) DE69930397T2 (enExample)
ES (1) ES2260931T3 (enExample)
GB (1) GB9819032D0 (enExample)
WO (1) WO2000012481A2 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9820767D0 (en) * 1998-09-23 1998-11-18 Cerebrus Ltd Chemical compounds VIII
GB9902047D0 (en) * 1999-01-29 1999-03-17 Cerebrus Ltd Chemical compounds XI
PL358481A1 (en) * 2000-03-17 2004-08-09 Alcon Inc. 6-hydroxy-indazole derivatives for treating glaucoma
US6956036B1 (en) 2000-03-17 2005-10-18 Alcon, Inc. 6-hydroxy-indazole derivatives for treating glaucoma
JP4204315B2 (ja) 2000-11-20 2009-01-07 ビオヴィトルム・アクチボラゲット（プブリクト） セロトニン５−ｈｔ２レセプターのアンタゴニストとしてのピペラジニルピラジン化合物
SE0004245D0 (sv) 2000-11-20 2000-11-20 Pharmacia Ab Novel compounds and their use
CA2432122A1 (en) 2000-12-20 2002-08-01 Bristol-Myers Squibb Pharma Company Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands
AU2002360819A1 (en) * 2001-12-28 2003-07-24 Bayer Corporation Cyclohexano- and cycloheptapyrazole derivative compounds, for use in diseases associated with the 5-ht2c receptor
TW200400177A (en) * 2002-06-04 2004-01-01 Wyeth Corp 1-(Aminoalkyl)-3-sulfonylindole and-indazole derivatives as 5-hydroxytryptamine-6 ligands
MXPA04012711A (es) 2002-06-19 2005-03-23 Biovitrum Ab Nuevos compuestos, su uso y preparacion.
CL2004000826A1 (es) 2003-04-25 2005-03-04 Pfizer Uso de un agonista para el receptor 5-ht2c para preparar un medicamento util en el tratamiento de la incontinencia urinaria provocada por estres, con la condicion de que el agonista no sea 1-[6-cloro-5-(trifluorometil)-2-piridinil]piperazina (org-129
GB0314967D0 (en) * 2003-06-26 2003-07-30 Hoffmann La Roche Piperazine derivatives
EP2248524A3 (en) 2004-08-25 2011-03-09 Takeda Pharmaceutical Company Limited Preventives/remedies for stress urinary incontinence and method of screening the same
WO2007132841A1 (ja) 2006-05-16 2007-11-22 Takeda Pharmaceutical Company Limited 縮合複素環化合物およびその用途
JP5520051B2 (ja) 2007-11-15 2014-06-11 武田薬品工業株式会社 縮合ピリジン誘導体およびその用途
WO2011071136A1 (ja) 2009-12-11 2011-06-16 アステラス製薬株式会社 線維筋痛症治療剤
WO2015066344A1 (en) 2013-11-01 2015-05-07 Arena Pharmaceuticals, Inc. 5-ht2c receptor agonists and compositions and methods of use
WO2019131902A1 (ja) 2017-12-27 2019-07-04 武田薬品工業株式会社 腹圧性尿失禁および便失禁の治療薬

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0232059A (ja) * 1988-07-18 1990-02-01 Kyowa Hakko Kogyo Co Ltd インダゾール誘導体
US5187166A (en) * 1990-07-31 1993-02-16 Nisshin Flour Milling Co., Ltd. Azabicyclo derivatives and their use as antiemetics
TW270114B (enExample) * 1993-10-22 1996-02-11 Hoffmann La Roche
JPH08225535A (ja) * 1994-11-15 1996-09-03 Dai Ichi Seiyaku Co Ltd インダゾール誘導体
WO1998030548A1 (en) * 1997-01-13 1998-07-16 Yamanouchi Pharmaceutical Co., Ltd. 5-HT2c RECEPTOR AGONISTS AND AMINOALKYLINDAZOLE DERIVATIVES

Also Published As

Publication number Publication date
JP2002525280A (ja) 2002-08-13
AU5636799A (en) 2000-03-21
EP1129078B1 (en) 2006-03-15
DE69930397T2 (de) 2006-11-30
US6552062B1 (en) 2003-04-22
WO2000012481A2 (en) 2000-03-09
CA2341612A1 (en) 2000-03-09
ATE320419T1 (de) 2006-04-15
EP1129078A2 (en) 2001-09-05
WO2000012481A3 (en) 2000-06-08
ES2260931T3 (es) 2006-11-01
DE69930397D1 (de) 2006-05-11

Similar Documents

Publication Publication Date Title
GB9819035D0 (en) Chemical compounds VII
GB9819032D0 (en) Chemical compounds IV
GB9819019D0 (en) Chemical compounds II
WO2000012482A3 (en) Indazole derivatives with 5-ht2 receptor activity
WO2000017170A3 (en) N1-substituted benzopyrazoles as inhibitors of 5-ht2 receptors
GB9902047D0 (en) Chemical compounds XI
AR029815A1 (es) Derivados aza-indolicos, un proceso para su preparacion, composicion farmaceutica, un metodo para su elaboracion y el uso de dichos derivados para la manufactura de un medicamento
HUP0301201A2 (hu) Kinazolinonok és kinazolinonokat tartalmazó készítmények
MY146111A (en) Acylaminopyrazoles as fgfr inhibitors
MXPA05006740A (es) Imidazoquinolinas arilo-sustituidas.
WO2001012602A8 (en) Condensed indoline derivatives and their use as 5ht, in particular 5ht2c, receptor ligands
GB0018272D0 (en) Chemical compounds IV
NZ336754A (en) Aminobenzophenones as inhibitors of interleukin and TNF
GB9901691D0 (en) Chemical compounds
AU6902800A (en) Pyridomorphinans and use thereof
NZ337048A (en) Use of N-[1-methyl-(substituted phenyl)ethyl]-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide derivatives to treat prostate cancer
AR029353A1 (es) Un compuesto derivado de pirazinoindol, uso del mismo, una composicion farmaceutica que lo comprende y un metodo para la fabricacion de dicha composicion

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)